Sangamo Therapeutics, Inc.
GENETIC MODIFICATION OF MITOCHONDRIAL GENOMES
Last updated:
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted genetic modification of mitochondrial DNA (mtDNA).
Status:
Application
Type:
Utility
Filling date:
21 Mar 2019
Issue date:
7 Jan 2021